Table 2. Intra- and interrater reliability of the sural nerve amplitude potential and conduction velocity using the point-of-care device for 44 subjects with type 1 and type 2 diabetes.
Total cohort (n = 44) | Type 1 Diabetes (n = 16) | Type 2 Diabetes (n = 28) | ||||
Median (IQR) | ICC | Median (IQR) | ICC | Median (IQR) | ICC | |
Intra-rater reliability | ||||||
SNAP (µV) | 6 (3–11) | 0.97 | 5 (3–13) | 0.97 | 5 (2–9) | 0.97 |
SNCV (m/s) | 50 (43–58) | 0.94 | 54 (45–58.5) | 0.96 | 48 (36–54) | 0.94 |
Inter-rater reliability | ||||||
SNAP (µV) | 5 (2–10) | 0.83 | 4 (2–6) | 0.74 | 3 (2–8) | 0.86 |
SNCV (m/s) | 50 (41–58) | 0.79 | 53 (44–58) | 0.68 | 46 (33–54) | 0.85 |
IQR = Interquartile range; ICC = Interclass correlation coefficients class(2,1); SNAP = sural nerve amplitude potential; SNCV = sural nerve conduction velocity.